EIKN insider transaction filings
Eikon Therapeutics, Inc. — 13 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-04. Screen EIKN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-04 | 4 | Klobuchar Michael A — Chief Operating Officer | Grant/award (A): 87,157 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Thorner Benjamin Bruno — See Remarks | Grant/award (A): 67,044 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Bowie Alfred Lloyd Jr. — Chief Financial Officer | Grant/award (A): 67,044 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Huffines Robert Luther — Director | Grant/award (A): 25,873 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Baynes Roy D. — Chief Medical Officer | Grant/award (A): 134,088 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | PERLMUTTER ROGER M — See remarks, Director | Grant/award (A): 268,176 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | FRAZIER KENNETH C — Director | Grant/award (A): 25,873 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | PERLMUTTER ROGER M — See remarks, Director | Conversion (C): 284,857 · Conversion (C): 1,268,891 (derivative) · Conversion (C): 855,512 (derivative) | EDGAR |
| 2026-02-09 | 4 | Column Group IV GP, LP — 10% owner Column Group IV-A, LP — 10% owner Column Group IV, LP — 10% owner Column Group Opportunity III, LP — 10% owner Column Group Opportunity III GP, LP — 10% owner TCG Opportunity III GP, LLC — 10% owner Kutzkey Tim — 10% owner Svennilson Peter — 10% owner | Conversion (C): 1,296,629 · Conversion (C): 1,403,568 · Conversion (C): 110,928 · Conversion (C): 44,249 · Conversion (C): 47,898 · Conversion (C): 3,785 · +11 more | EDGAR |
| 2026-02-06 | 4 | Wolfe Josh — Director, 10% owner | Purchase (P): 138,888 @ $18 · Purchase (P): 138,888 @ $18 · Conversion (C): 2,387,705 · Conversion (C): 1,151,540 · Conversion (C): 2,155,765 · Conversion (C): 10,000,000 (derivative) · +9 more | EDGAR |
| 2026-02-06 | 4 | Foresite Capital Management IV, LLC — 10% owner Foresite Capital Fund IV, L.P. — 10% owner Foresite Capital Management V, LLC — 10% owner Foresite Capital Fund V, L.P. — 10% owner Foresite Capital Opportunity Management V, LLC — 10% owner Foresite Capital Opportunity Fund V, L.P. — 10% owner Foresite Capital VI-A Management, LLC — 10% owner Foresite Capital VI-A, LLC — 10% owner | Conversion (C): 1,340,878 @ $0 · Conversion (C): 335,521 @ $0 · Conversion (C): 37,855 @ $0 · Conversion (C): 229,428 @ $0 · Conversion (C): 697,885 @ $0 · Conversion (C): 37,855 @ $0 · +23 more | EDGAR |
| 2026-02-06 | 4 | Lux Venture Partners V, LLC — 10% owner Wolfe Josh — Director, 10% owner Hebert Peter — 10% owner Lux Ventures V, L.P. — 10% owner Lux Co-Invest Opportunities II, L.P. — 10% owner Lux Total Opportunities, L.P. — 10% owner | Purchase (P): 138,888 @ $18 · Purchase (P): 138,888 @ $18 · Conversion (C): 2,387,705 · Conversion (C): 1,151,540 · Conversion (C): 2,155,765 · Conversion (C): 10,000,000 (derivative) · +9 more | EDGAR |
| 2026-02-06 | 4 | FRAZIER KENNETH C — Director | Purchase (P): 111,111 @ $18 | EDGAR |
Recent 8-K events — Eikon Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-01 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-06 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=EIKN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →